Business News›Prime›PRIMESHOTS›4 insights to kick-start your day, featuring PharmEasy’s funding winter
4 insights to kick-start your day, featuring PharmEasy’s funding winter
![4 insights to kick-start your day, featuring PharmEasy’s funding winter](https://img.etimg.com/thumb/msid-100686369,width-1015,height-761,imgsize-340010,resizemode-8/prime/primeshots/4-insights-to-kick-start-your-day-featuring-pharmeasys-funding-winter.jpg)
![4 insights to kick-start your day, featuring PharmEasy’s funding winter](https://img.etimg.com/thumb/msid-100686369,width-1015,height-761,imgsize-340010,resizemode-8/prime/primeshots/4-insights-to-kick-start-your-day-featuring-pharmeasys-funding-winter.jpg)
Synopsis
In Primeshots today: PharmEasy’s funding woes; an upbeat market; fresh call for chip subsidy, and Meta’s hate-speech inaction.
Uneasy times In the news. PharmEasy fails to get fresh funding, breaches covenant on Goldman Sachs loan, reports Economic Times Inside the news. A fast-growing startup, which was hotly pursued by venture capital-private equity investors during the bull run and raised about USD670 million in just a year (2021), is now struggling to close a USD150 million funding despite trying for a year. The down round, the capital crunch, an abandoned IPO plan
- FONT SIZEAbcSmallAbcMediumAbcLarge
ET
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.